Director Pavlov George purchases 25,000 shares across 3 transactions for $441,167.58 at MPLT, establishing 25.0K share position
Director Pavlov George executed 3 separate purchases totaling 25,000 shares for $441,167.58 between February 18–20, 2026, at prices ranging from $17.48 to $17.86 (blended average $17.65), establishing his first recorded position at MapLight Therapeutics. The transactions occurred in a stock trading near the midpoint of its 52-week range ($12.81–$21.08) and showing recent positive momentum: +5.5% over 30 days and +27.8% over 90 days. However, MapLight faces material financial headwinds, reporting net income of $-29,418,000.00, and the stock trades at a market cap of $811,269,830.04, making the scale and rationale for the director's entry position merit closer scrutiny.